About Hoth Therapeutics, Inc. - Common Stock (HOTH)
Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing innovative therapies for various dermatological conditions and related diseases. The company leverages its proprietary drug delivery systems and advanced therapeutics to address unmet medical needs, particularly in the treatment of skin disorders such as atopic dermatitis and psoriasis. Hoth's research is centered on bringing new solutions to patients by improving the efficacy and safety of existing treatments, thus enhancing the quality of life for those affected by challenging skin conditions. Read More
Hoth Therapeutics (NASDAQ: HOTH) is at the forefront of developing innovative therapies for unmet medical needs. The company will be presenting alongside world-class headliners such as Zack Kass, former Head of Go-To-Market at OpenAI where ChatGPT was created, and “Shark Tank” stars Kevin O’Leary, Robert Herjavec, and Daymond John.
